Q
QuantAbundance
Watchlist

AI Drug Discovery

Pure-play AI-driven drug-discovery platforms - generative biology, computational chemistry, antibody design, and protein-structure prediction applied to therapeutic pipelines. Companies where AI is the differentiator, not a buzzword bolted onto a traditional biotech. Seed members are 2026's 4 cleanest public listings on this thesis; the basket will grow as new IPOs land and Insitro-class private names go public.

Hypothetical· equal-weight buy at inception, mark-to-market today

May 18 → Nov 6 · 4/4 picks · equal-weight
+86.4%
AI Drug Discovery
-0.5%
SPY
+86.9%
alpha
topABCL+181.5%·SDGR+147.5%·RXRX+20.5%
dragGENB-4.0%·RXRX+20.5%·SDGR+147.5%

Antibody discovery

1 pick

Computational chemistry

1 pick

Generative biology

1 pick

Phenomics platform

1 pick

Frequently asked questions

What stocks are in the AI Drug Discovery watchlist?
The AI Drug Discovery watchlist tracks 4 tickers on QuantAbundance: ABCL, SDGR, GENB, RXRX.
What is the AI Drug Discovery watchlist?
Pure-play AI-driven drug-discovery platforms - generative biology, computational chemistry, antibody design, and protein-structure prediction applied to therapeutic pipelines. Companies where AI is the differentiator, not a buzzword bolted onto a traditional biotech. Seed members are 2026's 4 cleanest public listings on this thesis; the basket will grow as new IPOs land and Insitro-class private names go public.

Related research